Nanomedicine: ETPN appoints new Executive Committee

Patrick Boisseau, head of CEA-Leti’s nanomedicine program, was elected President of the European Technology Platform for Nanomedicine (ETPN) on December 5, 2012. The new Vice President, also French, is Nanobiotix CEO Laurent Lévy.
Founded in 2005, ETPN is coordinated by the European Commission and industry representatives to promote nanotechnology applications in medicine. The organization serves as an interface between nanomedicine scientists, clinicians, businesses, and EU government agencies. ETPN puts forward recommendations for potential research projects and facilitates the transfer of new technology deemed useful to Europe’s highly-competitive nanomedicine industry.

Contact: patrick.boisseau@cea.fr

Facebook

Twitter